Pan African Resources PLC (PAN)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 2,477.00 |
|---|---|
| 52-week range | 1,757.00 – 4,209.00 |
| Return, 1 month / 3 months | −12.1% / +17.1% |
| Return, 1 year / 3 years | +26.4% / +571.3% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 53.2% |
| Worst drawdown (1 year) | -49.1% |
| Average daily value traded | 18,296.87M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Pan African Resources is a gold mining company based in South Africa. It operates underground and surface gold mines and tailings retreatment operations in the country, producing gold doré and concentrate from ore mined at its sites. Its customers are gold refineries and precious metals markets that take its output for further processing. The company's activities span mining, processing and the recovery of gold from historical tailings, with its operations concentrated in South African goldfields.
Pan African Resources PLC trades under the code PAN on the Johannesburg Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Pan African Resources PLC (PAN) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 2,477.00 on 22 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 143 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.4% and over the last three months it rose 17.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.6% | ||
| From 52-week high | -36.2% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 17.1% | ||
| 6-month return | -27.6% | ||
| 12-month return, skipping the last month | 43.7% | ||
| Stability (higher is calmer) | 23 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.1% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 18,296.87M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −3.3% |
|---|---|
| 1 month | −12.1% |
| 3 months | +17.1% |
| 6 months | −27.6% |
| 1 year | +26.4% |
| 3 years | +571.3% |
| 5 years | +672.0% |
Signals
| 50-day / 200-day average | 2,705.21 / 2,833.79 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 115.86 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Nov 2022 | ZAC 18.0000 |
| 1 Dec 2021 | ZAC 18.0000 |
| 2 Dec 2020 | ZAC 14.0000 |
| 11 Dec 2019 | ZAC 2.2374 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.